Blog

  • September 14, 2022

Boosting a process with digital tools: Purification of oligonucleotides by ion exchange

Purification of oligonucleotides by ion exchange (IEX) is complex and many operating parameters need to be selected. There is a high interest in developing digital tools allowing to speed up process development, securing scale-up and decreasing waste. We present an innovative mechanistic model...

Read more

  • September 12, 2022

Interviewing experts on DSP intensification

Process intensification allows biomanufacturers to produce more product, often more quickly, using fewer raw materials and smaller equipment in less space. While there has been much focus on upstream process intensification, this approach can have significant impacts for downstream processing as well...

Read more

  • July 13, 2022

Roundtable : What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

In this roundtable from the new Q2 2022 issue of Pharma's Almanac , a distinguished panel of industry experts discusses the biggest challenge currently faced by the pharma/biopharma industry. The panel represents a diverse range of companies, including Ypso-Facto. The biopharmaceutical industry...

Read more

  • July 05, 2022

The history of Novasep through the eyes of its founder Roger-Marc Nicoud

In this exclusive document, Roger-Marc Nicoud returns to the saga of Novasep, a group he founded in 1996 but in which he no longer plays any part. In April 2022, following its purchase by investment company Bridgepoint (financial shareholder of PharmaZell), the French group Novasep...

Read more

  • June 28, 2022

Ypso-Ionic® - what our users say!

Ypso-Ionic® is a software solution for designing chromatographic processes.  It maximizes the value of experimental data and makes predictive simulation a game changer. But the best people to talk about it... are our customers! Check out the feedback ! "Ypso-Facto® have developed a unique...

Read more

  • June 08, 2022

Article : Digital tools support rational catalytic process development and evaluation

By Kilian Kobl - Project Manager at Ypso-Facto Progress in catalysis has enabled major breakthroughs in domains as various as agriculture, health and daily life, to only cite a few. Although new approaches of studying and developing catalytic processes emerge from time to time, people generally...

Read more

  • May 04, 2022

6 facts you didn’t know about Ypso-Facto

How great would it be to have a way to check if your chemical and bioprocess is optimized, safe, green and efficient? Well, that’s what we do for you at Ypso-Facto ! Ypso-Facto means  Y our P rocess S ecured and O ptimized …And it’s a FACT ! Ypso-Facto is a company which...

Read more

  • Bio
  • April 28, 2022

Article : Digital tools unleash the full potential of oligonucleotide production

By Kilian Kobl - Project Manager at Ypso-Facto Current oligo manufacturing processes are still somewhat larger scale versions of the initial processes conceived in the lab. Oftentimes, during development of an API, the choice of speed had to be made at the expense of conceiving a process that produces...

Read more

  • April 08, 2022

Article : Intensifying Downstream Processes

The need to increase efficiency and productivity is driving adoption. The biopharmaceutical industry is faced with the challenge of increasing efficiency and productivity to get needed medicines to patients more quickly and cost-effectively. Greater productivity and process efficiency are also...

Read more

Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.

Learn more

Contact Us
© Ypso-Facto 2014 - Powered by Ealys | Legal Information